FDA Seizes Illegal Medicines Worth ₹80,000 From Bhiwandi Eye Hospital

Mumbai: The Maharashtra Food and Drug Administration (FDA) seized illegal stock of medicines worth Rs80,000 from Aarav Eye Hospital in Bhiwandi on February 9 after a tip-off. This is the second such raid this year.

Earlier this month, the FDA busted a counterfeit medicine racket in Nagpur and seized 21,600 tablets of ciprofloxacin procured through a government contract. Samples of this drug were taken in March last year  but its results that it lacked any therapeutic value came in December.

In the present case, the eye hospital, owned by Dr Ashwin Bafna, didn’t have the licence to stock medicines. The hospital was established in 2005 and opened its second branch in Mira Road in 2017. The Bhiwandi branch opened in 2021.

A senior FDA official said that the pharmacist, Mohammad Ansari, didn’t have the licence required under the provisions of Drugs and Cosmetics Act, 1940 and Rules thereunder. Ansari initially told officials that he has the Pharmacists Registration Certificate issued by the Maharashtra Pharmacy Council but could not produce it; he later admitted not having any qualification as a pharmacist, the FDA official said. He added that the medicines seized can be sold only on the advice of a physician.

The official said, “Samples were drawn from the available stock and sale bills issued on and before February 9 were taken into custody.”

Related Posts

  • Pharma
  • July 26, 2024
  • 110 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 105 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD